Recent Advances in the HPPH-Based Third-Generation Photodynamic Agents in Biomedical Applications

Lixiao Fan,Zheng Jiang,Yu Xiong,Zepeng Xu,Xin Yang,Deying Gu,Mailudan Ainiwaer,Leyu Li,Jun Liu,Fei Chen
DOI: https://doi.org/10.3390/ijms242417404
IF: 5.6
2023-12-13
International Journal of Molecular Sciences
Abstract:Photodynamic therapy has emerged as a recognized anti-tumor treatment involving three fundamental elements: photosensitizers, light, and reactive oxygen species. Enhancing the effectiveness of photosensitizers remains the primary avenue for improving the biological therapeutic outcomes of PDT. Through three generations of development, HPPH is a 2-(1-hexyloxyethyl)-2-devinyl derivative of pyropheophorbide-α, representing a second-generation photosensitizer already undergoing clinical trials for various tumors. The evolution toward third-generation photosensitizers based on HPPH involves structural modifications for multimodal applications and the combination of multifunctional compounds, leading to improved imaging localization and superior anti-tumor effects. While research into third-generation HPPH is beneficial for advancing PDT treatment, equal attention should also be directed toward the other two essential elements and personalized diagnosis and treatment methodologies.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?